Investigation into conolidine has led to discovery of the opioid receptor in the body referred to as ACKR3/CXCR7. ACKR3 appears to be one of the most desired target for conolidine, which also disregards the opposite four classical opioid receptors(3). Given the system of action of conolidine contrary to opioids https://agency-social.com/story5863073/helping-the-others-realize-the-advantages-of-alternative-natural-pain-relief-to-replace-traditional-painkillers